Navigation Links
NovaScan decides against tax credits

Milwaukee, Wis. - NovaScan, an early-stage medical imaging company developing what it believes to be a novel tool for early detection of breast cancer, had to bypass angel tax credits from the State of Wisconsin to finance clinical trials for its emerging technology.

The company instead has raised a total of $385,000 from a combination of five......

Full article >>> otype imaging device that might be able to distinguish between the electrical properties of healthy tissue and malignant tissue. By identifying the electrical properties of different tissues, including healthy and malignant, the company might be able to promote earlier detection of different cancers.

NovaScan has targeted breast cancer as its initial application, and it might eliminate o......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 08/15/06


Related biology technology :

1. State pledges $50K to NovaScan, Platypus
2. NovaScan qualifies for investor tax credits
3. Protector RNase Inhibitor Enhance the Protection of RNA against Degradation
4. Protecting your business against online brand abuse
5. Journalist warns against late arrival to the tech party
6. Wisconsin companies on the front lines in the war against cancer
7. Guarding against patent enforcement
8. Third Wave files patent suits against Digene, Chiron and Bayer
9. Third Wave sued by one firm; gets injunction against another
10. Third Wave wins patent lawsuit against California firm
11. Wisconsin Supreme Court rules against Microsoft
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):